Activity

Filter

Cancel
Date Panel Item Activity
8 actions
Bleeding and Platelet Disorders v1.19 ACTB Zornitza Stark Phenotypes for gene: ACTB were changed from Syndromic thrombocytopaenia to Thrombocytopenia 8, with dysmorphic features and developmental delay, MIM# 620475
Bleeding and Platelet Disorders v1.18 ACTB Zornitza Stark edited their review of gene: ACTB: Changed phenotypes: Thrombocytopenia 8, with dysmorphic features and developmental delay, MIM# 620475
Bleeding and Platelet Disorders v0.31 ACTB Zornitza Stark changed review comment from: Six unrelated individuals reported with heterozygous variants clustered in the 3'-coding region of ACTB and clinical features distinct from BWCFF, including mild developmental disability, microcephaly, and thrombocytopenia with platelet anisotropy.
Sources: Expert list; to: Six unrelated individuals reported with heterozygous variants clustered in the 3'-coding region of ACTB (exons 5 and 6) and clinical features distinct from BWCFF, including mild developmental disability, microcephaly, and thrombocytopenia with platelet anisotropy.
Sources: Expert list
Bleeding and Platelet Disorders v0.31 ACTB Zornitza Stark Marked gene: ACTB as ready
Bleeding and Platelet Disorders v0.31 ACTB Zornitza Stark Gene: actb has been classified as Green List (High Evidence).
Bleeding and Platelet Disorders v0.31 ACTB Zornitza Stark Classified gene: ACTB as Green List (high evidence)
Bleeding and Platelet Disorders v0.31 ACTB Zornitza Stark Gene: actb has been classified as Green List (High Evidence).
Bleeding and Platelet Disorders v0.30 ACTB Zornitza Stark gene: ACTB was added
gene: ACTB was added to Bleeding Disorders. Sources: Expert list
Mode of inheritance for gene: ACTB was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: ACTB were set to 30315159
Phenotypes for gene: ACTB were set to Syndromic thrombocytopaenia
Review for gene: ACTB was set to GREEN
Added comment: Six unrelated individuals reported with heterozygous variants clustered in the 3'-coding region of ACTB and clinical features distinct from BWCFF, including mild developmental disability, microcephaly, and thrombocytopenia with platelet anisotropy.
Sources: Expert list